Zobrazeno 1 - 10
of 22
pro vyhledávání: '"Wilmin Bartolini"'
Autor:
David Aggen, Meredith McKean, Nehal Lakhani, Babar Bashir, Jean Hoffman-Censits, Omar Alhalabi, Elizabeth Guancial, Isaac Bowman, Alan Tan, Trupti Lingaraj, Marissa Timothy, Nerymar Ortiz-Otero, Wilmin Bartolini, Katherine Kacena, Karim Malek, Sergio Santillana, Jason Luke
Publikováno v:
Regular and Young Investigator Award Abstracts.
Autor:
Trupti Lingaraj, Marissa Timothy, Nerymar Ortiz-Otero, Wilmin Bartolini, Katherine Kacena, Karim Malek, Sergio Santillana
Publikováno v:
Regular and Young Investigator Award Abstracts.
Autor:
Niels Borgstein, Lin Chang, Wilmin Bartolini, Ken Tripp, Jennifer Hanlon, Brian E. Lacy, Ramesh Boinpally, Madhuja Mallick, Susan M. Fox, Amy Kassebaum, Nicholas Omniewski, Jessica L. Abel, Baha Moshiree, Wieslaw Bochenek, Elizabeth P. Shea
Publikováno v:
American Journal of Gastroenterology. 116:1929-1937
INTRODUCTION Linaclotide improves abdominal pain and constipation in patients with constipation-predominant irritable bowel syndrome (IBS-C). Patients report additional bothersome abdominal symptoms of bloating and discomfort. The intention of this s
Autor:
Darren M. Brenner, Brian E. Lacy, Alexander C. Ford, Wilmin Bartolini, James Wu, Elizabeth P. Shea, Wieslaw Bochenek, Ramesh Boinpally, Cristina Almansa
Publikováno v:
The American journal of gastroenterology.
These post hoc analyses provide clinically relevant data concerning time to response for individual irritable bowel syndrome with constipation (IBS-C) symptoms after linaclotide use.Time-to-response data were pooled from 4 randomized controlled trial
Autor:
Anthony Lembo, Braden Kuo, Ramesh Boinpally, Ella Li, Madhuja Mallick, Wieslaw Bochenek, Wilmin Bartolini
Publikováno v:
Alimentary pharmacologytherapeuticsREFERENCES. 57(2)
MD-7246, a delayed-release formulation of linaclotide, is designed to target the ileocaecal junction and caecum with the aim of relieving abdominal pain independently of bowel function.To evaluate the efficacy, safety and dose-response of MD-7246 in
Autor:
David S. Reasner, Gregory S. Sayuk, Niels Borgstein, Elizabeth P. Shea, William D. Chey, Susan M. Fox, Ramesh Boinpally, Wieslaw Bochenek, Wilmin Bartolini, Kenneth Tripp
Publikováno v:
The American Journal of Gastroenterology
Introduction Immediate-release (IR) formulation of linaclotide 290 μg improves abdominal pain and constipation (APC) in patients with irritable bowel syndrome (IBS) with constipation. Delayed-release (DR) formulations were developed on the premise t
Autor:
David S. Reasner, Ramesh Boinpally, Benjamin D. Gold, Stavra A. Xanthakos, Hanna Kwak, Madhuja Mallick, Christopher R. O'Dea, Mitchell B. Cohen, Wilmin Bartolini, Taryn Weissman, Pei Ge, Nicholas CaJacob
Publikováno v:
Journal of pediatric gastroenterology and nutrition. 73(6)
Guanylate cyclase-C (GC-C) agonists, which increase intestinal secretion and accelerate transit, are used to treat chronic constipation and constipation-predominant irritable bowel syndrome and are being evaluated for pediatric use. Prior studies sug
Autor:
Benjamin S. Amidon, Marta Sanchez-Martin, Wilmin Bartolini, Sakeena Syed, Karen McGovern, Lan Xu, Jeffrey Ecsedy, X. Michelle Zhang, Alex Constan, Alfredo C. Castro
Publikováno v:
Cancer Research. 82:2156-2156
The Hippo pathway is critical to cancer progression, biogenesis, metastasis, and therapeutic resistance. Many cancer indications have a high frequency of mutations in the Hippo pathway. These pro-tumor mutations lead to constitutive TEAD transcriptio
Autor:
Ramesh Boinpally, Brian E. Lacy, James Wu, Wilmin Bartolini, Wieslaw Bochenek, Cristina Almansa, Elizabeth P. Shea, Alexander C. Ford, Darren M. Brenner
Publikováno v:
American Journal of Gastroenterology. 116:S228-S228
Autor:
Lin Chang, Wieslaw Bochenek, Wilmin Bartolini, Lesley A. Houghton, James Wu, Alexander C. Ford, Ramesh Boinpally, Elizabeth P. Shea, Cristina Almansa
Publikováno v:
American Journal of Gastroenterology. 116:S240-S240